Boardroom Alpha
Meeting calendar
BATRA · Annual meeting · Wednesday, May 20, 2026

Atlanta Braves Holdings Inc

1 nominee · 2 ballot items.

Elect Wonya Y. Lucas as a Class III director and ratify the selection of KPMG LLP as the Company’s independent auditor for the 2026 fiscal year.

Market cap
$3.6B
1Y TSR
+14.8%
Board grade
C
Record date
Mar 27, 2026
Filing
DEF 14A
Meeting concluded · May 20, 2026

Follow how the vote landed and what changed on Atlanta Braves Holdings Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot2

  1. 1

    Election of Wonya Y. Lucas as Class III Director

    ManagementBoard: FOR

    Elect Wonya Y. Lucas to continue serving as a Class III member of the Board until the 2029 Annual Meeting of Stockholders or her earlier resignation or removal.

  2. 2

    Ratification of Selection of KPMG LLP as Independent Auditor for 2026 Fiscal Year

    ManagementBoard: FOR

    Ratify the selection of KPMG LLP as the Company’s independent auditor for the fiscal year ending December 31, 2026.

Director elections

Nominees on the ballot1

Independent
Tenure on this board
3.0 yrs
Also a director at
Comcast Corp (CMCSA)
Ownership

Top institutional holders10

Latest 13F quarter
1GAMCO INVESTORS, INC. ET AL3.4%2,173,206$102M
2GABELLI FUNDS LLC1.4%917,332$43M
3VANGUARD CAPITAL MANAGEMENT LLC0.8%527,224$25M
4RENAISSANCE TECHNOLOGIES LLC0.5%334,700$16M
5BlackRock, Inc.0.4%272,276$13M
6STATE STREET CORP0.3%216,061$10M
7DIMENSIONAL FUND ADVISORS LP0.3%210,741$10M
8BlackRock, Inc.0.3%203,402$10M
9MORGAN STANLEY0.3%197,062$9M
10GEODE CAPITAL MANAGEMENT, LLC0.3%184,726$9M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Atlanta Braves Holdings Inc 2026 annual meeting?
Atlanta Braves Holdings Inc (BATRA) holds its 2026 annual shareholder meeting on Wednesday, May 20, 2026.
What is the record date for the Atlanta Braves Holdings Inc 2026 meeting?
The record date for the Atlanta Braves Holdings Inc 2026 meeting is Friday, March 27, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Atlanta Braves Holdings Inc's 2026 meeting?
The board is presenting 1 director nominee at the Atlanta Braves Holdings Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Atlanta Braves Holdings Inc 2026 meeting?
Shareholders will vote on 2 proposals at the Atlanta Braves Holdings Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer